Eli Lilly Licenses ADDF’s SpeechDx Dataset for Alzheimer’s Research

The Alzheimer’s Drug Discovery Foundation (ADDF) announced on October 28, 2026 that Eli Lilly and Company has licensed SpeechDx, a longitudinal speech-and-biomarker dataset built b…

阿尔茨海默病能从说话声里听出来？礼来拿语音数据集研究